&Partners’s Hamilton Lane HLNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.45M Sell
18,391
-1,917
-9% -$170K 0.01% 1200
2026
Q1
$2.02M Sell
20,308
-264
-1% -$32.4K 0.01% 897
2025
Q4
$2.76M Buy
20,572
+1,310
+7% +$165K 0.01% 713
2025
Q3
$2.59M Buy
19,262
+2,209
+13% +$333K 0.02% 647
2025
Q2
$2.42M Buy
17,053
+11,325
+198% +$1.71M 0.02% 595
2025
Q1
$843K Buy
5,728
+2,352
+70% +$358K 0.01% 894
2024
Q4
$507K Buy
3,376
+1,611
+91% +$287K 0.01% 1070
2024
Q3
$297K Buy
+1,765
New +$256K 0.01% 1102

Other funds holding HLNE

&Partners's HLNE Position: Q2 2026 in Review

&Partners reduced its Hamilton Lane (HLNE) stake by 9.4% in Q2 2026, selling an estimated $170K and leaving 18,391 shares worth $1.45M. The position accounts for 0.01% of the portfolio, ranked #1200.

&Partners first reported a position in HLNE in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.76M in Q4 2025. 380 funds tracked by Wall St. Rank hold HLNE as of Q2 2026.

  • &Partners held 18,391 shares of Hamilton Lane worth $1.45M as of Q2 2026.
  • &Partners sold 1,917 Hamilton Lane shares in Q2 2026, an estimated $170K.
  • Hamilton Lane made up 0.01% of &Partners's portfolio in Q2 2026, its #1200 holding.
  • &Partners first reported a position in Hamilton Lane in Q3 2024 and has held it in 8 quarters since.
  • &Partners's Hamilton Lane position peaked at $2.76M in Q4 2025.
  • 380 funds tracked by Wall St. Rank held Hamilton Lane as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.